Skip to main content

Advertisement

SpringerLink
Log in

Emulsion-templated synthesis and in vitro characterizations of niosomes for improved therapeutic potential of hydrophobic anti-cancer drug: tamoxifen

  • Research Paper
  • Published:
Journal of Nanoparticle Research Aims and scope Submit manuscript

Abstract

Hydrophobic nature of anti-cancer drugs not only imparts different pharmacokinetic barriers in drug delivery, but also associates with off-target toxicity and low-dose exposure of drug at the tumor site which is subsequently responsible for the development of multi-drug resistance. This study describes a water-in-oil emulsion templated reverse-phase evaporation strategy, using Span 120 as non-ionic surfactant, for the synthesis of tamoxifen-loaded niosomes. The dicetyl phosphate and Span 120 were used to engineer niosomes for sustained drug release over 12 h and improved surface morphology. The spherical niosomes were 260–300 nm in size with − 34.6 mV zeta potential. The scanning electron microscopy revealed a rough texture on the surface of niosomes. Niosomes released the drug in first-order and sustained release pattern up to 12 h. Cholesterol was embedded in the outer hydrophobic surface of niosomes, via inclusion in oil phase, to enhance the interaction with lipid bilayer of the cells. Niosomes were able to improve the cellular uptake of tamoxifen and introduced apoptosis (29%) as major mechanism of cell death as compared to necrosis (17%). DSC and XRD studies revealed the crystalline nature of the drug inside niosomes while FTIR displayed chemical stability of the drug after entrapment. After encapsulation inside niosomes, the anti-cancer activity of tamoxifen was improved up to five times with IC50 reduced from 1 μM to 0.2 μM against MCF-7 cells. Cytotoxicity and sulforhodamine B assay revealed the apoptotic cell death. The unloaded niosomes alone showed no toxicity to the cells and presented a biocompatible nanoscale delivery platform for hydrophobic anti-cancer drugs.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Agarwal R, Katare O, Vyas S (2001) Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 228:43–52

    Article  CAS  Google Scholar 

  • Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–515

    Article  CAS  Google Scholar 

  • Azeem A, Anwer MK, Talegaonkar S (2009) Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 17:671–689

    Article  CAS  Google Scholar 

  • Bakshi H et al (2010) DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pac J Cancer Prev 11:675–679

    Google Scholar 

  • Basha M, Abd El-Alim SH, Shamma RN, Awad GE (2013) Design and optimization of surfactant-based nanovesicles for ocular delivery of clotrimazole. J Liposome Res 23:203–210

    Article  CAS  Google Scholar 

  • Baum M, Budzar A, Cuzick J, Forbes J, Houghton J, Klijn J, Sahmoud T (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet (London, England) 359:2131–2139

    Article  CAS  Google Scholar 

  • Bayindir ZS, Yuksel N (2010) Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049–2060

    Article  CAS  Google Scholar 

  • Bourquin J, Milosevic A, Hauser D, Lehner R, Blank F, Petri-Fink A, Rothen-Rutishauser B (2018) Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv Mater 30:1704307

    Article  Google Scholar 

  • Date AA, Joshi MD, Patravale VB (2007) Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 59:505–521

    Article  CAS  Google Scholar 

  • Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R, Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805–816

    Article  CAS  Google Scholar 

  • Devaraj GN, Parakh S, Devraj R, Apte S, Rao BR, Rambhau D (2002) Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci 251:360–365

    Article  CAS  Google Scholar 

  • Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97:1652–1662

    Article  CAS  Google Scholar 

  • Garay RP, El-Gewely R, Armstrong JK, Garratty G, Richette P (2012) Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv 11:1319–1323

    Article  Google Scholar 

  • Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP–dependent transporters. Nat Rev Cancer 2:48–58

    Article  CAS  Google Scholar 

  • Guinedi AS, Mortada ND, Mansour S, Hathout RM (2005) Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82

    Article  CAS  Google Scholar 

  • Gursoy RN, Benita S (2004) Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 58:173–182

    Article  Google Scholar 

  • Hao Y, Zhao F, Li N, Yang Y, Li K (2002) Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80

    Article  CAS  Google Scholar 

  • Javed I, Hussain SZ, Ullah I, Khan I, Ateeq M, Shahnaz G, Rehman H, Razi MT, Shah MR, Hussain I (2015) Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B. J Mater Chem B 3:8359–8365

    Article  CAS  Google Scholar 

  • Javed I, Hussain SZ, Shahzad A, Khan JM, ur-Rehman H, Rehman M, Usman F, Razi MT, Shah MR, Hussain I (2016) Lecithin-gold hybrid nanocarriers as efficient and pH selective vehicles for oral delivery of diacerein—in-vitro and in-vivo study. Colloid Surf B 141:1–9

    Article  CAS  Google Scholar 

  • Ke PC, Lin S, Parak WJ, Davis TP, Caruso F (2017) A decade of the protein corona. ACS Nano 11:11773–11776

    Article  CAS  Google Scholar 

  • Kedar R, Bourne TH, Collins W, Campbell S, Powles T, Ashley S, Cosgrove D (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318–1321

    Article  CAS  Google Scholar 

  • Khoee S, Hassanzadeh S, Goliaie B (2007) Effects of hydrophobic drug–polyesteric core interactions on drug loading and release properties of poly (ethylene glycol)–polyester–poly (ethylene glycol) triblock core–shell nanoparticles. Nanotechnology 18:175602

    Article  Google Scholar 

  • Krishnamurthy S, Vaiyapuri R, Zhang L, Chan JM (2015) Lipid-coated polymeric nanoparticles for cancer drug delivery. Biomater Sci 3:923–936

    Article  CAS  Google Scholar 

  • Lin G-J, Jiang G-B, Xie Y-Y, Huang H-L, Liang Z-H, Liu Y-J (2013) Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and western blotting analysis of ruthenium (II) complexes. J Biol Inorg Chem 18:873–882

    Article  CAS  Google Scholar 

  • Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592–599

    Article  CAS  Google Scholar 

  • Mehta S, Jindal N (2013) Formulation of tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs. Colloid Surf B 101:434–441

    Article  CAS  Google Scholar 

  • Moghimi SM, Szebeni J (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Red 42:463–478

    Article  CAS  Google Scholar 

  • Mukherjee B, Patra B, Layek B, Mukherjee A (2007) Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study. Int J Nanomedicine 2:213

    CAS  Google Scholar 

  • Pandey SK, Ghosh S, Maiti P, Haldar C (2015) Therapeutic efficacy and toxicity of tamoxifen loaded PLA nanoparticles for breast cancer. Int J Biol Macromol 72:309–319

    Article  CAS  Google Scholar 

  • Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:615–627

    Article  CAS  Google Scholar 

  • Priyadarsini RV, Murugan RS, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S (2010) The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol 649:84–91

    Article  Google Scholar 

  • Rehman M, Madni A, Shi D, Ihsan A, Tahir N, Chang KR, Javed I, Webster TJ (2017) Enhanced blood brain barrier permeability and glioblastoma cell targeting via thermoresponsive lipid nanoparticles. Nanoscale 9:15434–15440

    Article  CAS  Google Scholar 

  • Ruckmani K, Sankar V (2010) Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech 11:1119–1127

    Article  CAS  Google Scholar 

  • Shaker DS, Shaker MA, Hanafy MS (2015) Cellular uptake, cytotoxicity and in-vivo evaluation of tamoxifen citrate loaded niosomes. Int J Pharm 493:285–294

    Article  CAS  Google Scholar 

  • Shenoy DB, Amiji MM (2005) Poly (ethylene oxide)-modified poly (ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 293:261–270

    Article  CAS  Google Scholar 

  • Signorell RD, Luciani P, Brambilla D, Leroux J-C (2018) Pharmacokinetics of lipid-drug conjugates loaded into liposomes. Eur J Pharm Biopharm 128:188–199

    Article  CAS  Google Scholar 

  • Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y (2014) Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed 53:12320–12364

    CAS  Google Scholar 

  • Usman F, Javed I, Hussain SZ, Ranjha NM, Hussain I (2016) Hydrophilic nanoparticles packed in oral tablets can improve the plasma profile of short half-life hydrophobic drugs. RSC Adv 6:94896–94904

    Article  CAS  Google Scholar 

  • Wang M, Siddiqui G, Gustafsson OJR, Käkinen A, Javed I, Voelcker NH, Creek DJ, Ke PC, Davis TP (2017) Plasma proteome association and catalytic activity of stealth polymer-grafted Iron oxide nanoparticles. Small 13

  • Zhang D, Tan T, Gao L, Zhao W, Wang P (2007) Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies. Drug Dev Ind Pharm 33:569–575

    Article  CAS  Google Scholar 

  • Zhao Y-Z, Lu CT, Zhang Y, Xiao J, Zhao YP, Tian JL, Xu YY, Feng ZG, Xu CY (2013) Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. Int J Pharm 454:302–309

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, 54000, Pakistan

    Hamid Saeed Shah

  2. College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan

    Fazala Khalid & Sajid Bashir

  3. Department of Pharmaceutical Sciences, COMSATS Institute of Information Technology, Abbottabad, 22060, Pakistan

    Muhammed Hasham Bin Asad

  4. Laboratory INSERM UMR 1097, Aix-Marseille University, 163, Parc Scientifique et Technologique de Luminy, Avenue de Luminy, Bâtiment TPR2, Case 939, 13288, Marseille, France

    Muhammed Hasham Bin Asad

  5. Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, 90112, Thailand

    Kashif-Ur-Rehman Khan

  6. Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, 60000, Pakistan

    Faisal Usman

  7. Drug Delivery System Excellence Center, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, 90112, Thailand

    Faisal Usman

  8. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 399 Royal Parade, Parkville, Victoria, 3052, Australia

    Ibrahim Javed

Authors
  1. Hamid Saeed Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fazala Khalid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sajid Bashir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Muhammed Hasham Bin Asad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kashif-Ur-Rehman Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Faisal Usman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ibrahim Javed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Faisal Usman or Ibrahim Javed.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, H.S., Khalid, F., Bashir, S. et al. Emulsion-templated synthesis and in vitro characterizations of niosomes for improved therapeutic potential of hydrophobic anti-cancer drug: tamoxifen. J Nanopart Res 21, 25 (2019). https://doi.org/10.1007/s11051-019-4464-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11051-019-4464-y

Keywords

Search

Navigation